Items 1 ~ 10 of 2265, Page 1 of 227 
 03/09/2010 - World Health Organization (WHO)
Good procurement practices for artemisinin-based antimalarial medicines
 03/09/2010 - World Health Organization (WHO)
Guidelines for the treatment of malaria, second edition
 08/26/2009 - Centers for Disease Control and Prevention (CDC)
Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children
 08/06/2009 - U. S. Food and Drug Administration (FDA)
Guidance for Industry: Pharmaceutical Components at Risk for Melamine Contamination
 07/07/2009 - National Institutes of Health (NIH)
The NIH Guidelines for Human Stem Cell Research
 01/15/2009 - U. S. Food and Drug Administration (FDA)
Guidance for Industry : Regulation of Genetically Engineered Animals Containing Heritable Recombinant DNA Constructs
 01/05/2009 - ACCF/SCAI/STS/AATS/AHA/ASNC
2009 Appropriateness Criteria for Coronary Revascularization
 12/03/2008 - American Academy of Neurology (AAN)
Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review)
 12/03/2008 - American Academy of Neurology (AAN)
Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of laboratory and genetic testing (an evidence-based review)
 11/30/2008 - World Health Organization (WHO)
Toxicology of melamine

<<  <  [1[2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  >  >>